On Demand: Scaling Home-Based Decongestion in Heart Failure With FUROSCIX® (Furosemide Injection)-Webinar Slides

Webinar Slides

Pdf Summary

This MedAxiom presentation outlines how to scale a home-based decongestion pathway for heart failure using Furoscix (furosemide injection). It argues that worsening congestion often develops before patients need emergency or inpatient care, creating an opportunity to intervene earlier, reduce hospitalizations, and improve symptoms. The need is reinforced by the burden of heart failure hospital use, the frequency of residual congestion at discharge, and the growing emphasis on scalable ambulatory heart failure care models.<br /><br />The document emphasizes that successful implementation requires more than a medication—it needs a complete, reliable pathway. Key elements include defining the clinical use case, establishing governance and pharmacy partnerships, building reliable access through prior authorization and delivery processes, standardizing patient selection and treatment protocols, and measuring performance through clinical response and downstream utilization.<br /><br />A central message is that “the pathway is only as strong as its connections.” The workflow must include clear steps for identifying appropriate patients, securing access, initiating therapy with education and home administration, monitoring symptoms and safety, reassessing response, and deciding whether to escalate care or continue treatment. Gaps in ownership, workflow integration, or monitoring can delay treatment and increase variation.<br /><br />The roadmap described includes program objectives, phased rollout, governance, pre-launch preparation, pharmacy integration, patient selection, protocols, and metrics. A roundtable discussion is intended to address practical implementation questions: where to begin, who should be involved, how to operationalize the pathway, and how to determine whether it is working. The presentation also notes Furoscix Readyflow is now available and encourages review of the published roadmap.

Keywords

heart failure

decongestion pathway

Furoscix

furosemide injection

home-based treatment

ambulatory care

hospitalization reduction

congestion management

patient selection

pharmacy integration